Navigation Links
Glycerin Proven to Improve Bruising and Swelling Caused By Trauma to Skin
Date:5/15/2009

Study Findings Confirm Glycerin Accelerates the Healing Process

in Damaged Tissue and Cells

MANDEVILLE, La., May 15 /PRNewswire/ -- Today, a leading expert in the field of non-surgical skin rejuvenation announced results from a study demonstrating that glycerin helps to speed up the healing process of damaged tissue and cells, resulting in less bruising and skin discoloration.

In a double-blinded, placebo-controlled clinical study of a glycerin-based bruise-reaction product, 65 percent of the patients who experienced bruising after filler injection procedures saw a reduction in the severity and duration of bruising with a single post-procedural application of Bruise Relief(TM) serum versus a placebo. The product was found to reduce the appearance of bruising with no reported side effects.

"Glycerin, as an active ingredient in Bruise Relief(TM), helps with the rejuvenation process of the skin," said Dr. Mary P. Lupo, dermatologist and non-surgical skin rejuvenation expert. "The most common treatment-related complication from filler injections is bruising. I have seen a significant decrease in bruising after treatments with an application of Bruise Relief(TM). Post-procedural Botox and leg vein injections (sclerotherapy) may also benefit from this single post-procedural application."

Glycerin, a humectant, attracts water and helps lubricate and hydrate the skin's cells. It is a thick, water-soluble liquid. Bruises occur when capillary blood vessels break and blood and fluids pool underneath the skin. Glycerin's hydrating properties enable the body to seal off the broken capillaries and blood vessels caused by trauma to the skin and help prevent the pooling of blood and fluids.

Bruise Relief(TM), available in a gel or serum formulation, also contains vitamins, nutrients and antioxidants and is non-toxic and safe for all ages and skin types. Bruise Relief (TM) gel is available nationwide at all CVS stores as well as at Jewel/Osco, Albertsons, Acme, Shaw's and other fine pharmacies across the country.

"Bruise Relief(TM) has been in my family for nearly five generations," said Barbara Cranner, executive vice president of Dr. Holmquist Healthcare, LLC. "We developed the product for the mass market with my stepfather, Dr. Nelson Holmquist, and we are thrilled to share an old family recipe with the world."

About Dr. Holmquist Healthcare, LLC

Dr. Holmquist Healthcare, LLC is a family- and majority-woman-owned and operated company. Headquartered in Mandeville, Louisiana, the company is dedicated to the revitalization of New Orleans, and manufactures the company's product lines at local plants. Dr. Holmquist Healthcare's product line currently features Bruise Relief(TM), a topical skin care product in a gel and serum formulation designed to eliminate the appearance of bruising and skin discoloration. Learn more about Dr. Holmquist Healthcare and its products at http://www.bruiserelief.com.

CONTACT: Holly Campbell, Levick Strategic Communications, +1-202-973-1337, hcampbell@levick.com


'/>"/>
SOURCE Dr. Holmquist Healthcare, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
2. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
3. Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial
4. Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial
5. Derma Sciences MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers
6. Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
7. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
8. Clinically Proven Treatment Offers Help to Rosacea Sufferers
9. Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term
10. Study Shows: New Blood Test Proven Six Times More Effective For Tuberculosis Control
11. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... , July 21, 2017 Did you know that PhRMA ... 2016? Or that combined spending on brand medicines, generics and the ... with brands accounting for just half of this (7 percent)? Or ... thirds of the world,s venture capital investments in high-growth biopharmaceutical startups? ... ...
(Date:7/19/2017)... RALEIGH, N.C. , July 19, 2017  Mako ... Veteran Affairs, and the Military Family Assistance Fund (MFA) ... Louisiana to visit with their families one ... the funding to coordinate the travel and logistics needed ... supporting our deployed soldiers and their families. We just ...
(Date:7/15/2017)... , July 15, 2017 Enterin Inc., a ... treat Parkinson,s disease (PD), today announced the completion of a ... investors New Ventures III, as well as the participation of ... absolutely thrilled to have the support of New Ventures III ... investors as validation of the potential of our platform technology ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... In ... researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform ... surgery, though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... concussion rates are on the rise, say researchers presenting their work at the ... Ontario, Canada. , “The combination of evaluating the patterns of change in concussion ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a leading provider ... JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. McCarter, formerly ... Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, brings 30 ...
(Date:7/20/2017)... (PRWEB) , ... July 20, ... ... provider of enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, ... world’s largest healthcare services providers. , According to Peter Ohrenberger, sales director ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
Breaking Medicine News(10 mins):